Sarah Kordovan1, Pia Preissler1,2, Anne Kamphausen3, Carsten Bokemeyer1, Karin Oechsle1. 1. 1 Department of Oncology, Hematology, and Bone Marrow Transplantation with section of Pneumology, University Medical Center Hamburg-Eppendorf , Germany . 2. 2 Department of Medical Psychology, University Medical Center Hamburg-Eppendorf , Germany . 3. 3 Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf , Germany .
Abstract
OBJECTIVE: This study was a prospective evaluation of feasibility, acceptance, and potential beneficial effects of music therapy in terminally ill cancer patients on a specialized palliative care inpatient ward. METHODS: Intervention had to consist of at least two sessions, but frequency and duration was left to the patients` decision. Different music therapy methods were offered to the patient at the beginning of every session. Patients rated their subjective benefit. Disease-related and sociodemographic factors were considered as potentially influencing factors. RESULTS: A total of 166 music therapy sessions were performed with 41 patients (average, 4; range, 2-10). Average session duration was 41 minutes (range, 20-70). Most favored methods were therapeutic conversation in 84% of sessions; listening to relaxing music, 39%; playing an instrument, 31%; and music-lead imagination, 11%. Receptive music therapy was applied in 45%, active forms in 25%, a combination of both in 7%, and therapeutic conversation only in 23%. Music therapy was rated to be "helpful" in 68%. Positive effects were significantly associated with frequency (p = 0.009) and duration (p = 0.040), living in a partnership (p = 0.017), having children (p = 0.035), psycho-oncologic therapy (p = 0.043), experience with music therapy (p = 0.007), role of music in life (p = 0.035), playing an instrument (p = 0.021), and singing regularly (p = 0.003). CONCLUSION: Music therapy techniques, especially receptive methods, are feasible and well accepted in terminally ill cancer patients. Therapeutic conversation seems to play an important role. Frequency and duration of music therapy, previous experience with music and music therapy, as well as sociodemographic factors influence positive effects of music therapy.
OBJECTIVE: This study was a prospective evaluation of feasibility, acceptance, and potential beneficial effects of music therapy in terminally ill cancerpatients on a specialized palliative care inpatient ward. METHODS: Intervention had to consist of at least two sessions, but frequency and duration was left to the patients` decision. Different music therapy methods were offered to the patient at the beginning of every session. Patients rated their subjective benefit. Disease-related and sociodemographic factors were considered as potentially influencing factors. RESULTS: A total of 166 music therapy sessions were performed with 41 patients (average, 4; range, 2-10). Average session duration was 41 minutes (range, 20-70). Most favored methods were therapeutic conversation in 84% of sessions; listening to relaxing music, 39%; playing an instrument, 31%; and music-lead imagination, 11%. Receptive music therapy was applied in 45%, active forms in 25%, a combination of both in 7%, and therapeutic conversation only in 23%. Music therapy was rated to be "helpful" in 68%. Positive effects were significantly associated with frequency (p = 0.009) and duration (p = 0.040), living in a partnership (p = 0.017), having children (p = 0.035), psycho-oncologic therapy (p = 0.043), experience with music therapy (p = 0.007), role of music in life (p = 0.035), playing an instrument (p = 0.021), and singing regularly (p = 0.003). CONCLUSION: Music therapy techniques, especially receptive methods, are feasible and well accepted in terminally ill cancerpatients. Therapeutic conversation seems to play an important role. Frequency and duration of music therapy, previous experience with music and music therapy, as well as sociodemographic factors influence positive effects of music therapy.
Authors: Kathleen A Lynch; Nicholas Emard; Kevin T Liou; Karen Popkin; Michael Borten; Ogechi Nwodim; Thomas M Atkinson; Jun J Mao Journal: J Pain Symptom Manage Date: 2020-11-19 Impact factor: 3.612
Authors: Susann Kobus; Alexandra M Buehne; Simone Kathemann; Anja K Buescher; Elke Lainka Journal: Int J Environ Res Public Health Date: 2022-05-27 Impact factor: 4.614
Authors: Pia Preissler; Sarah Kordovan; Anneke Ullrich; Carsten Bokemeyer; Karin Oechsle Journal: BMC Palliat Care Date: 2016-05-12 Impact factor: 3.234
Authors: D M Hansra; K McIntyre; J Ramdial; S Sacks; C S Patrick; J Cutler; B McIntyre; K Feister; M Miller; A K Taylor; F Farooq; J Antunez de Mayolo; E Ahn Journal: Evid Based Complement Alternat Med Date: 2018-04-12 Impact factor: 2.629
Authors: Inmaculada Valero-Cantero; Francisco Javier Martínez-Valero; Milagrosa Espinar-Toledo; Cristina Casals; Francisco Javier Barón-López; María Ángeles Vázquez-Sánchez Journal: BMC Palliat Care Date: 2020-05-02 Impact factor: 3.234